DrugPatentWatch Database Preview
Details for Patent: 7,919,483
» See Plans and Pricing
Which drugs does patent 7,919,483 protect, and when does it expire?
Patent 7,919,483 protects XIMINO and SOLODYN and is included in two NDAs.
This patent has thirteen patent family members in ten countries.
Summary for Patent: 7,919,483
| Title: | Method for the treatment of acne |
| Abstract: | A method for treatment of acne with tetracyclines is provided. A lower sustained dose and no loading dose is employed, with an optional once-a-day dosing regimen. |
| Inventor(s): | Wortzman; Mitchell (Scottsdale, AZ), Plott; R. Todd (Briscoe, TX), Bhatia; Kuljit (Nesconset, NY), Patel; Bhiku (Chandler, AZ) |
| Assignee: | Medicis Pharmaceutical Corporation (Scottsdale, AZ) |
| Application Number: | 11/166,817 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,919,483 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; Delivery; |
Drugs Protected by US Patent 7,919,483
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-001 | Jul 11, 2012 | RX | No | No | Start Trial | Start Trial | TREATMENT OF ACNE | Start Trial | ||||
| Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-003 | Jul 11, 2012 | RX | No | No | Start Trial | Start Trial | TREATMENT OF ACNE | Start Trial | ||||
| Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-005 | Jul 11, 2012 | RX | No | No | Start Trial | Start Trial | TREATMENT OF ACNE | Start Trial | ||||
| Medicis | SOLODYN | minocycline hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 050808-001 | May 8, 2006 | DISCN | Yes | No | Start Trial | Start Trial | TREATMENT OF ACNE | Start Trial | ||||
| Medicis | SOLODYN | minocycline hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 050808-008 | Aug 27, 2010 | AB | RX | Yes | No | Start Trial | Start Trial | TREATMENT OF ACNE | Start Trial | |||
| Medicis | SOLODYN | minocycline hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 050808-004 | Jul 23, 2009 | AB | RX | Yes | No | Start Trial | Start Trial | TREATMENT OF ACNE | Start Trial | |||
| Medicis | SOLODYN | minocycline hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 050808-007 | Aug 27, 2010 | AB | RX | Yes | No | Start Trial | Start Trial | TREATMENT OF ACNE | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,919,483
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2006262428 | Start Trial | |||
| Canada | 2613273 | Start Trial | |||
| China | 101208097 | Start Trial | |||
| European Patent Office | 1898925 | Start Trial | |||
| Israel | 188331 | Start Trial | |||
| Japan | 2008543936 | Start Trial | |||
| Japan | 2013213047 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
